Skip to content

Clareon CCWET6 (UDI 00380652456487)Recalls & reported problems

Alcon Laboratories, Inc. · Clareon Vivity Toric UVA · Class 3 · Implant

All models of Clareon (1142)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00380652456487), received between May 13, 2025 and May 13, 2025 — classified as 1 malfunction.

The most frequently reported specific device problem is “Product Quality Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 1 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Product Quality Problem1

Patient problems

  • Corneal Edema1
  • Visual Disturbances1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMay 13, 2025Product Quality Problem; Product Quality Problem

    A PHYSICIAN REPORTED THAT DURING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, WHEN THE LENS WAS IN THE EYE, NOTICED THAT THE AXIS MARKS ON THE IOL WERE ABOUT 30 DEGREES COUNTERCLOCKWISE FROM THE HAPTIC BASE. PHYSICIAN MADE THE ASSUMPTION THAT THE TORIC AXIS MARKS WERE CORRECTLY PLACED ON THE OPTIC AND POSITIONED THE LENS WITH THE IOL AXIS MARKS AT 144 DEGREES, LEAVING THE HAPTICS AT AXIS 110 DEGREES. PHYSICIAN INFORMED PATIENT THAT THIS WAS AN UNUSUAL SITUATION THAT NOT ENCOUNTERED BEFORE AND PHYSICIAN MADE THE JUDGEMENT THAT THE AXIS MARKS WERE LIKELY CORRECTLY POSITIONED ON THE IOL, BUT THAT THERE WAS A CHANCE THAT THE AXIS MARKS ARE INCORRECT IN WHICH CASE PATIENT MAY NEED A LENS ROTATION OR POSSIBLY AN IOL EXCHANGE. THERE WAS NO PATIENT HARM. PATIENT HAD MILD CORNEAL EDEMA AT DAY ONE POST OPERATIVE VISIT WITH MILD HYPEROPIC ASTIGMATISM ON AUTOREFRACTION BUT THIS WAS LIKELY TO CHANGE WITH RESOLUTION OF MILD CORNEAL EDEMA. ADDITIONAL INFORMATION RECEIVED STATING THAT ONE-WEEK POST OPERATION PATIENT WAS VERY HAPPY. PHYSICIAN DILATED LEFT EYE AND IOL AXIS MARKS ARE AT 138 DEGREES (TARGETED 144 DEGREES). THEY WILL PROCEED WITH CATARACT SURGERY ON RIGHT EYE NEXT WEEK, ALSO TO USE A T

    Patient problems: Corneal Edema; Visual Disturbances

    MAUDE report 22015656 ↗

Other intraocular lens devices

All intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page